Buspar and Triumeq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Buspar (buspirone hydrochloride) and Triumeq (abacavir sulfate; dolutegravir sodium; lamivudine). Common drug interactions include anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Buspar and Triumeq. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Buspar?

Buspar has active ingredients of buspirone hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 20,462 Buspar users. Check the latest studies of Buspar.

What is Triumeq?

Triumeq has active ingredients of abacavir sulfate; dolutegravir sodium; lamivudine. It is often used in hiv infection. eHealthMe is studying from 6,900 Triumeq users. Check the latest studies of Triumeq.



On Jul, 26, 2026

14 people who take Buspar and Triumeq together, and have interactions are studied.

Buspar and Triumeq drug interactions.

What are the common drug interactions of Buspar and Triumeq, by gender? *:

female:

n/a

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Emotional distress
  3. Fatigue (feeling of tiredness)
  4. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  5. Injury
  6. Nephrolithiasis (calculi in the kidneys)
  7. Osteonecrosis (death of bone)
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Tooth loss
  10. Fracture

What are the common drug interactions of Buspar and Triumeq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Suicidal ideation

20-29:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Discomfort
  3. Emotional distress
  4. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)
  5. Injury
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Osteoporosis (bones weak and more likely to break)
  8. Pain
  9. Bone density decreased

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Blood urine present
  3. Chronic kidney disease
  4. Emotional distress
  5. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  6. Glycosuria (excretion of glucose into the urine)
  7. Multiple injuries
  8. Pain
  9. Renal failure (kidney dysfunction)

40-49:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Emotional distress
  4. Pain
  5. Adrenal mass
  6. Back pain
  7. Confusional state
  8. Dizziness
  9. Erectile dysfunction
  10. Renal impairment (severely reduced kidney function)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Bone density decreased
  3. Bone loss
  4. Chronic kidney disease
  5. Dysuria (painful or difficult urination)
  6. Emotional distress
  7. Fatigue (feeling of tiredness)
  8. Nephrolithiasis (calculi in the kidneys)
  9. Osteonecrosis (death of bone)
  10. Pain

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Bone density decreased
  3. Emotional distress
  4. Fracture
  5. Osteoporosis (bones weak and more likely to break)
  6. Pain
  7. Prostate cancer
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. Insomnia (sleeplessness)
  10. Vomiting

What are the existing conditions these people have? *

  1. Depression: 2 people, 14.29%
  2. Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 7.14%
  3. Thyroid Diseases: 1 person, 7.14%
  4. Bacterial Infection: 1 person, 7.14%
  5. Blood Testosterone Decreased: 1 person, 7.14%
  6. Bone Loss: 1 person, 7.14%
  7. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 1 person, 7.14%
  8. Diabetes: 1 person, 7.14%
  9. Erection Problems: 1 person, 7.14%
  10. Eye Disorder: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Buspar and Triumeq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Buspar and Triumeq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Buspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Triumeq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Buspar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Triumeq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on buspirone hydrochloride and abacavir sulfate; dolutegravir sodium; lamivudine (the active ingredients of Buspar and Triumeq, respectively), and Buspar and Triumeq (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: